Under the agreement, the South Korean company will help the country prepare for future pandemics by developing a homegrown vaccine. — Bloomberg
SEOUL: SK bioscience Co, a pharmaceutical affiliate of South Korea’s SK Group, says it has joined hands with Thailand’s state-run drugmaker to build vaccine manufacturing and development infrastructure in the South-East Asian country.
SK bioscience and Thailand’s Government Pharmaceutical Organisation (GPO) signed a memorandum of understanding (MoU) on Tuesday.
